ChiCTR1800015349
尚未开始
/
/
/
2018-03-15
/
/
惡性難治腦癇症
使用天麻水提物紓緩惡性難治腦癇症患者的發作情況
使用天麻水提物紓緩惡性難治腦癇症患者的發作情況
使用天麻水提物紓緩惡性難治腦癇症患者的發作情況
非随机对照试验
治疗新技术
Non-randomized
/
N/A
/
120
/
1990-01-01
1990-01-01
/
1. Subject aged 18 years or above; 2. Subject has a diagnosis of refractory epilepsy; 3. Persistent seizures despite sequential or add-on therapy with 2 or more antiepileptic drugs 4. At least one or more non-seizure symptoms including and not limited to dizziness, vertigo, headache, insomnia, cognitive impairment and behavioural problem; 5. Subject able to speak and listen Chinese.；
登录查看1. Abnormal renal and liver functions at baseline; 2. Concomitant antipsychotic drugs or serotonin-reuptake inhibitors; 3. Substance abuse; 4. Pregnancy or breastfeeding; 5. Active history of malignancy; 6. Unwillingness to give consent for herbal supplementation with GR by the subject or the care-taker of the subject; 7. Neurodegenerative conditions with predicted survival less than 6 months; 8. Active history of cardiovascular conditions.；
登录查看The Chinese University of Hong Kong
/
Medaverse2024-11-24
小药说药2024-11-24
亚泰制药2024-11-24
BioArtMED2024-11-23
新康界2024-11-23
Rimonci2024-11-23
肝脏时间2024-11-23
精准药物2024-11-23
亚泰制药2024-11-23
昌郁医药2024-11-22
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
